Eribulin Mesylate 68462-0770-20

Package NDC

68462-0770-20

Manufacturer: Glenmark Pharmaceuticals Inc., Usa
Dosage Form: Injection
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: August 5, 2025
Listing Expires: December 31, 2026
Application: ANDA218142

Need to source Eribulin Mesylate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Eribulin Mesylate	.5 mg/mL

Drug Class

Microtubule Inhibition [PE]Microtubule Inhibitor [EPC]

Selected Package

68462-0770-20Selected

1 VIAL, SINGLE-DOSE in 1 CARTON (68462-770-20) / 2 mL in 1 VIAL, SINGLE-DOSE